For AI assistants & researchers — machine-readable summary of this page
What this page is: Delvantic's full research page for MSCI Inc. (MSCI) — AI-driven forensic equity research: mechanical valuation models (DCF, EPV, anchored-PE, scenario) plus three independent AI lenses (Quality / Value / Sentiment). Everything below is rendered server-side; you are not missing content that requires JavaScript. All scores are predictions and research opinions, not financial advice.
Our current read (analysis of 2026-10-07): Designation Watch · Gem Score -5 (−100…+100 Quality+Value blend) · Quality 85 · Value -65 · Sentiment -36 (timing only, not weighted) · Composite fair value $313.66 vs $549.78 at analysis
Page map (sections in order; each card carries a stable
reference-name attribute you can cite):
profile-header/price-overview— company profile, live quote, market capextended-analysis— the core: three AI lens reads with findings, scores, and the analyst memofuture-predictions— our forward price-band predictionsmarket-narrative/ai-findings/gpt-critique— narrative context, cross-model findings, and an adversarial critique of our own analysis (near the end of the document)- Members-only sections (render as login gates for anonymous readers):
price-history,income-trend,key-metrics,financials(statement tables),insider-trading. The analysis above is public; the raw data tables require a free account.
More for machine readers: site briefing at
/llms.txt ·
any ticker resolves at delvantic.com/stock/TICKER ·
raw inputs are public-company filings and market data (via licensed data feeds);
every model, score, lens read, and prediction on this page is Delvantic's own analysis.
MSCI Inc.
MSCI NYSEMSCI Inc. is a financial services company that provides research-based data, analytics, and indexes for the global investment industry. Its products are used by asset managers, asset owners, hedge funds, wealth managers, banks, insurers, and corporates to support portfolio construction, risk analysis, performance measurement, and asset allocation. MSCI’s offerings include equity, fixed income, real estate, thematic, factor, ESG, and climate indexes, along with analytics and private assets solutions that help clients evaluate markets and manage investment workflows. The company also supplies tools and research for benchmarking, portfolio monitoring, and sustainability-focused decision-making. Headquartered in New York, MSCI plays a central role in global capital markets by providing widely used reference standards and decision-support solutions across public and private markets.
Price Overview
Price History (1 Year)
Revenue & Net Income Trend
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics TTM · through Jun 30, 2026
EPS (Diluted): 18.28
Total Equity: -$2.69B
Shares: 74,293,000
Total Debt: $6.38B
Cash: $356.40M
EBITDA: $1.88B
Total Debt: $6.38B
Cash: $356.40M
Revenue: $3.33B
Revenue: $3.33B
Revenue: $3.33B
Total Equity: -$2.69B
Tax Rate: 14.7%
Equity: -$2.69B
Total Debt: $6.38B
Cash: $356.40M
Current Liabilities: $1.61B
Long-Term Debt: $6.38B
Total Debt: $6.38B
Total Equity: -$2.69B
Shares: 74,293,000
Shares: 74,293,000
CapEx: -$30.22M
Shares: 74,293,000
Stock Price: $549.78
Net Income: $1.36B
Industry Benchmarks
Income Statement (Annual)
Last updated: Sep 17, 2026 3:34pm (20d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $2.0B | $2.2B | $2.5B | $2.9B | $3.1B |
| Cost of Revenue | $358.7M | $404.3M | $446.6M | $514.4M | $550.4M |
| Gross Profit | $1.7B | $1.8B | $2.1B | $2.3B | $2.6B |
| Operating Expenses | $596.1M | $636.6M | $697.7M | $813.2M | $870.5M |
| Operating Income | $1.1B | $1.2B | $1.4B | $1.5B | $1.7B |
| Net Income | $726.0M | $870.6M | $1.1B | $1.1B | $1.2B |
| EBITDA | $1.2B | $1.4B | $1.7B | $1.7B | $1.9B |
| EPS | $8.80 | $10.78 | $14.45 | $14.09 | $15.72 |
| EPS (Diluted) | $8.70 | $10.72 | $14.39 | $14.05 | $15.69 |
Balance Sheet (Annual)
Last updated: Sep 7, 2026 1:25pm (30d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $1.4B | $993.6M | $461.7M | $409.4M | $515.3M |
| Total Current Assets | $2.1B | $1.7B | $1.4B | $1.3B | $1.6B |
| Total Assets | $5.5B | $5.0B | $5.5B | $5.4B | $5.7B |
| Current Liabilities | $1.3B | $1.3B | $1.5B | $1.6B | $1.8B |
| Long-Term Debt | $4.2B | $4.5B | $4.5B | $4.5B | $6.2B |
| Total Liabilities | $5.7B | $6.0B | $6.3B | $6.4B | $8.4B |
| Total Equity | -$163.5M | -$1.0B | -$739.8M | -$940.0M | -$2.7B |
| Retained Earnings | $3.0B | $3.5B | $4.2B | $4.8B | $5.4B |
Cash Flow (Annual)
Last updated: Sep 7, 2026 1:25pm (30d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $936.1M | $1.1B | $1.2B | $1.5B | $1.6B |
| Capital Expenditure | -$13.5M | -$13.6M | -$22.8M | -$33.8M | -$39.3M |
| Free Cash Flow | $922.6M | $1.1B | $1.2B | $1.5B | $1.5B |
| Acquisitions (net) | -$949.0M | $0 | -$727.3M | -$27.5M | $0 |
| Net Debt Issued / (Repaid) | $751.9M | $347.8M | -$8.8M | -$2.2M | $1.7B |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | -$198.4M | -$1.4B | -$504.2M | -$885.3M | -$2.5B |
| Net Change in Cash | $120.9M | -$427.9M | -$531.9M | -$52.3M | $106.0M |
Growth Trends (YoY %)
Last updated: Sep 17, 2026 3:34pm (20d ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | +10.0% | +12.5% | +12.9% | +9.7% |
| Gross Profit Growth | +9.5% | +12.9% | +12.5% | +10.3% |
| Operating Income Growth | +10.9% | +14.7% | +10.4% | +12.1% |
| Net Income Growth | +19.9% | +31.9% | -3.4% | +8.4% |
| EBITDA Growth | +16.3% | +26.3% | +1.9% | +10.0% |
Dividend History (Last 20)
Last updated: Sep 17, 2026 4:27pm (20d ago)| Date | Dividend | Declaration | Record | Payment |
|---|---|---|---|---|
| 2026-08-14 | $2.05 | — | — | — |
| 2026-05-15 | $2.05 | — | — | — |
| 2026-02-13 | $2.05 | — | — | — |
| 2025-11-14 | $1.80 | — | — | — |
| 2025-08-15 | $1.80 | — | — | — |
| 2025-05-16 | $1.80 | — | — | — |
| 2025-02-14 | $1.80 | — | — | — |
| 2024-11-15 | $1.60 | — | — | — |
| 2024-08-16 | $1.60 | — | — | — |
| 2024-05-16 | $1.60 | — | — | — |
| 2024-02-15 | $1.60 | — | — | — |
| 2023-11-08 | $1.38 | — | — | — |
| 2023-08-10 | $1.38 | — | — | — |
| 2023-05-11 | $1.38 | — | — | — |
| 2023-02-16 | $1.38 | — | — | — |
| 2022-11-09 | $1.25 | — | — | — |
| 2022-08-11 | $1.25 | — | — | — |
| 2022-05-12 | $1.04 | — | — | — |
| 2022-02-17 | $1.04 | — | — | — |
| 2021-11-10 | $1.04 | — | — | — |
Deep Analysis
Risk : Reward — upside vs downside from this company's own quarters
Computed 2026-10-06 02:03A +1σ run of quarters pays -63%; a −1σ run costs 71%. Ratio -0.9:1 (μ 11.6%, σ 4.3% floored by sector, 16 pairs).
Older method (repeat-worst-quarter): -0.8 : 1
| Case | Growth | Margin | Fair value | vs price ($549.78) |
|---|---|---|---|---|
| Bull — recovery | +21% | 35.0% | $238.22 | -57% |
| Base — stabilizes | +14% | 35.0% | $193.77 | -65% |
| Bear — keeps slipping | +7% | 34.6% | $154.94 | -72% |
| Stress — last quarter repeats | +9% | 35.0% | $167.94 | -69% |
| Upside — a +1σ run of quarters (v2) | +16% | 35.0% | $203.23 | -63% |
| Stress — a −1σ run of quarters (v2) | +7% | 35.0% | $157.53 | -71% |
Narrative Economics
market-narrative step).
Growth Outlook
Analyzed 2026-09-17 16:37The question every valuation on this page silently assumes: is this company likely to grow? Judged forward — the business, its category, the world — against what's already printed.
Claude Reading
MSCI's raw numbers are pristine: TTM revenue of ~$3.33B (summing the four quarters through 2026-06-30) up from $2.99B a year prior — that's 11.6% YoY, consistent with the 11.1% five-year CAGR. Quarterly revenue trajectory is monotonic: $772.7M → $793.4M → $822.5M → $850.8M → $867.0M. Gross margin sits at 83%, operating margin 55.7%, net margin 40.7%, and FCF conversion runs above 95% ($1.55B FCF on $1.20B NI in 2025). This is a subscription-heavy, asset-based-fee franchise with fortress unit economics. Negative book equity (-$2.65B) reflects aggressive buybacks funded by $6.2B of debt, not distress — leverage is ~3.5x EBITDA against contractually recurring cash flows, which is manageable but not trivial in a higher-rate regime.
The synthesis verdict of $314 fair value (-43% to current $549.78) reads as too aggressive on the downside. At $39.3B market cap plus ~$5.7B net debt = ~$45B EV, MSCI trades at 25.6x EV/EBITDA and ~29x FCF. To justify the DCF-implied $314, you need to assume FCF growth reverts to sub-10% and the terminal multiple compresses to ~18-20x — plausible in a bear case, but MSCI's actual trailing revenue growth is 11.6% accelerating (Q2 2026 rev +12.2% YoY vs Q1 2025's slower base), and index-linked AUM fees have a structural compounding component the DCF likely under-models. That said, the thesis-eval headline is directionally correct: at 12.3x sales, the market is paying for durable double-digit growth plus multiple maintenance, and the historical earnings CAGR of just 7% (vs revenue 11%) hints at margin plateau or SBC/interest drag.
The prior models contradict themselves in useful ways. Pre-flight calls it a durable mature earner with fortress moat; synthesis says overvalued by 43%; market-forces calls it neutral hold with downside skew; narrative layer admits fundamentals anchor $315 but concedes the platform-monopoly premium is "durable." The thesis score of -8 (essentially balanced) is more honest than the synthesis' -43% verdict. Insider activity is noise — a 450-share sale against tiny award grants and two small purchases tells me nothing at a $39B cap. The "Macro Headwinds" flag matters more: rising rates pressure MSCI two ways — higher interest expense on $6.2B debt, and slower AUM growth in the asset-based-fee segment if equities compress. The contrarian bear case worth taking seriously isn't ESG commoditization (overblown) — it's that index licensing fee compression from the BlackRock/Vanguard duopoly is a real, quantifiable headwind that management has been quietly conceding on earnings calls.
My read: overvalued but not by 43%. Fair value is closer to $430-460 (roughly 22-24x FCF, 20x EV/EBITDA, in line with peers like S&P Global and Moody's on comparable growth), implying ~15-20% downside rather than the synthesis' 43%. The $314 anchor assumes a re-rating that doesn't happen for high-quality compounders absent a fundamental break — and I see no break in the quarterly trajectory. The Q1 2026 net income of $406M (47.7% margin) looks like a one-time tax or item benefit that inflated the TTM NI figure; normalized margins are ~40%, which is where I'd underwrite. At $549.78, you're paying a full price for a business that will likely grow FCF 9-11% and return most of it — a fine long-term hold, a poor entry point. I partially dissent from synthesis (agree on direction, disagree on magnitude) and land closer to market-forces' "neutral with downside skew." No new money here; existing holders shouldn't panic-sell a 25-year compounder over a 15% overvaluation.
GPT Reading
MSCI’s numbers still read like a best-in-class tollbooth. On the trailing twelve months through 2026-06-30, revenue is $3.33B and net income is $1.36B, for a 40.7% net margin; operating margin is 55.7% and gross margin 83.0%. That is not just “good business” profitability, it is franchise pricing power. The quarterly progression is also cleaner than the bearish framing suggests: revenue went from $724.7M eight quarters ago to $867.0M last quarter, and the latest quarter grew 12.2% year over year versus $772.7M. TTM revenue growth versus the prior TTM is about 13%, while TTM net income rose roughly 15% from about $1.18B to $1.36B. For a company already above $3B of revenue, that combination of low-capex intensity, high incremental margins, and double-digit top-line growth is rare. The cash flow backs it up: 2025 free cash flow was $1.55B on $1.59B of operating cash flow with only $39.3M of capex, so this is economically much closer to a software royalty stream than a conventional financial firm.
What stands out to me is that the valuation is demanding but not obviously absurd if these economics persist. At $39.3B market cap and a 30.1x trailing P/E, the equity is priced like a durable compounder, which MSCI arguably is. Against TTM earnings of $1.36B, investors are paying up for persistence, not just near-term growth. The sales multiple of 12.3x and EV/revenue of 14.4x would be uncomfortable for a cyclical or capital-intensive business, but MSCI is neither. The balance sheet looks ugly on paper — $6.20B of debt, only $515.3M of cash, negative equity of $2.65B, current ratio below 0.9 — yet those are symptoms of an aggressively financialized capital return model more than operating weakness. With annualized earnings power above $1.3B and free cash generation that historically tracks earnings closely, leverage is meaningful but serviceable. I do not read this as a broken capital structure; I read it as a premium franchise optimized for buybacks and shareholder extraction.
That said, I still come out negative on the stock at $549.78 because the premium has outrun the growth. The business has earned a premium multiple, but not any premium multiple. Revenue has compounded around 11% and earnings around 7% over the cited historical period; even using the stronger recent trend, you are still looking at low-teens revenue growth from an already very mature asset-light franchise. Paying 30x trailing earnings and 25.6x EV/EBITDA for that requires confidence that the current 11-13% revenue growth cadence and 40%+ net margins are both durable through market cycles. That may happen, but the upside from here looks constrained because the multiple already assumes very little friction in index-linked AUM, analytics demand, and pricing. On a rough owner-earnings lens, a $39.3B market cap against something like $1.5B of free cash flow is a mid-20s FCF multiple for a company that is excellent but not growing like a true software disruptor.
The best argument against my caution is straightforward: the market is paying for uniqueness, and the numbers support that uniqueness better than the bearish models do. Recent quarterly revenue growth actually accelerated from 6.8% in 2024-09 to 12.2% in 2026-06 on the comparable quarters shown, and quarterly net income hit as high as $406.0M in 2026-03. If MSCI can keep compounding revenue at 11-13% while holding operating margins around 55%, earnings can grow faster than the current multiple compression risk implies. The negative equity is not inherently alarming for a company with this level of recurring revenue and minimal capex, and insider activity includes open-market purchases in May 2026, modest though they are. In other words, a smart bull would say this is exactly the kind of wide-moat compounder that always screens “expensive” and usually stays that way. I weigh that differently because the present price leaves too little room for any slowdown; quality is undeniable, but quality can still be overpaid for.
What would change my mind is not a story but a continuation of the recent slope. If the next few quarters show revenue sustaining above roughly $900M per quarter with year-over-year growth still at 12%+ and net margins staying around 40% despite the larger base, I would be more willing to underwrite the current multiple. Likewise, if free cash flow on a TTM basis pushes convincingly toward $1.8B without leverage becoming a bigger issue, the stock could justify remaining above $550. Conversely, if revenue growth slips back to high single digits while the market still values the company at 12x sales and 30x earnings, I would expect a material rerating lower. My base case is simpler: superb company, stretched stock.
Grok Reading
MSCI’s trailing-twelve-month picture through mid-2026 is a cash compounder executing with unusual consistency. Sequential quarterly revenue marched from $793.4 M to $822.5 M to $850.8 M to $867.0 M, producing a TTM top line of roughly $3.33 B and year-over-year growth still sitting near 12 %. Net income over the same four quarters totals about $1.36 B, for a 40.7 % net margin that sits comfortably inside the 34–48 % band the company has printed for years. The 2025 full-year numbers already showed $3.13 B revenue, $1.71 B operating profit and $1.55 B free cash flow on only $39 M of capex—conversion north of 95 %. Gross margin holds at 83 % and operating margin at 56 %, confirming an asset-light index-and-analytics franchise that scales without meaningful incremental capital. The balance-sheet optics look ugly (negative equity of $2.65 B, $6.2 B of debt, cash of only $515 M), yet the leverage is the deliberate residue of aggressive buybacks and dividends rather than operational stress; debt is roughly four turns of free cash flow and the interest burden is easily covered by the cash engine. Revenue CAGR of 11.1 % and FCF CAGR of 10.5 % over the multi-year window are respectable for a mature earner, but they are not the 20 %-plus trajectory the current multiple implies.
At $549.78 the stock trades at 30× trailing earnings, 12.3× sales and 25.6× EV/EBITDA. Those multiples price in a durable re-acceleration or an indefinite expansion of the passive/ESG/factor TAM that has already been the core narrative for a decade. The raw numbers do not yet show that acceleration: recent revenue growth is still mid-teens at best and the secondary signal flags a decelerating quarterly trend. The business quality is real—the index licensing moat, switching costs and annuity-like analytics subscriptions are visible in the margin structure—but the market is paying a software multiple for what remains, at root, a high-teens-ROIC financial-data oligopoly whose historical free-cash-flow growth has averaged closer to 10–14 %. That gap between what the cash flows have delivered and what 30× earnings requires is the central tension.
The strongest counter-argument is that MSCI is simply too good a franchise to mark to a normal multiple. A smart opponent would note the 83 % gross margin, the near-perfect FCF conversion, the structural tailwinds of global AUM growth and the fact that every major asset manager still benchmarks to MSCI indexes; they would argue that 25–28× is the new floor for this kind of infrastructure asset and that the negative equity is irrelevant because the company can keep levering the balance sheet to retire shares. They would also point to the recent 15 % earnings year-over-year print and the small insider purchases as evidence that the growth runway is intact. I weigh that case seriously—the moat is genuine and the cash generation is fortress-like—but I still discount it because the absolute valuation already embeds almost all of those virtues. Paying 12× sales for mid-teens growth leaves almost no margin of safety if passive flows moderate, if fee pressure on indexes intensifies, or if ESG-related spend simply stops expanding at the prior rate. Quality deserves a premium; it does not automatically justify a 40–70 % premium to a disciplined DCF anchored on 8–11 % organic growth.
What would flip the view is clear: two consecutive quarters of revenue growth re-accelerating through 15 % while operating margin holds or expands, accompanied by evidence that asset-based fee AUM is compounding faster than the broader market, or a material reduction in net leverage that signals management is no longer stretching the balance sheet to manufacture EPS. Conversely, any print showing sequential revenue growth slipping below 8 % or a sustained compression in net margin toward the low 30s would confirm the multiple compression risk already visible in the models.
Qwen Reading local experiment · off-panel
The most glaring contradiction in this dataset is not the valuation multiple, but the balance sheet. MSCI reports a market cap of $39.3B and a P/E of ~30x, yet its total equity is negative $2.65B. This is not a data error; it is the mathematical result of aggressive share buybacks funded by debt. With $6.20B in total debt against only $515M in cash, the company is leveraging its cash flow to shrink the share count, artificially inflating EPS and ROA (24.7%) while eroding the equity cushion. The "Mature Earner" classification is misleading; this is a highly leveraged financial engineering play disguised as a software utility. The negative equity means that in a severe downturn, the debt load of $6.2B is a direct threat to solvency, not just a cost of capital. The market is pricing this as a "fortress moat" business, but the balance sheet reveals a company that is betting its entire existence on uninterrupted, high-margin cash flows to service debt that exceeds its cash position by a factor of twelve.
The revenue growth story is also decoupling from the valuation. While the 5-year revenue CAGR is a healthy 11.1%, the quarterly data shows a clear deceleration: revenue grew from $772.7M in Q2 2025 to $867.0M in Q2 2026, but the net margin compressed from 39.3% to 39.4% (flat) while the prior year’s Q2 was 39.3%. More concerning is the Q1 2026 spike in net income ($406M, 47.7% margin) which likely includes one-time gains or tax benefits, as Q2 2026 normalized back to $342M (39.4%). The "recent_earnings_yoy" of 15.2% is a red herring driven by this volatility. The core business is growing at ~11%, but the market is paying 12.25x sales and 25.5x EV/EBITDA. For a company with negative equity and a current ratio of 0.89 (below 1.0, indicating liquidity tightness), this multiple is exorbitant. The "platform-monopoly" narrative is strong, but monopolies with negative equity and sub-1.0 current ratios are not "fortresses"; they are leveraged bets on perpetual growth.
The strongest case against my bearish read is the sheer quality of the free cash flow. MSCI generated $1.55B in FCF on $3.13B in revenue, a 49% FCF margin. This is exceptional. The operating cash flow of $1.59B covers the interest expense on $6.2B of debt many times over. If the business is truly a "cash cow" with 82% gross margins and 55% operating margins, the debt is manageable, and the negative equity is a sign of shareholder returns, not distress. The "Net Insider Buying" signal, while small in share count (120-240 shares), suggests management is not fleeing. The "Strong Cash Flow Quality" tag is accurate. If MSCI can maintain 11% growth and 50% FCF margins, the 30x P/E is justified by the durability of the cash flows. The risk is not the debt, but the growth. If growth slows to 5%, the multiple compresses, and the leverage becomes a problem.
What would change my mind is a clear demonstration that the debt is being paid down, not just refinanced. If the next two quarters show a reduction in total debt below $5.5B while maintaining the 11% revenue growth, the negative equity becomes a non-issue, and the valuation is supported by the cash flow. Conversely, if the debt increases further or if the current ratio drops below 0.8, the "fortress" narrative collapses, and the stock is overvalued by a wide margin. The key metric to watch is not revenue, but the debt-to-FCF ratio. Currently, it is 4.0x ($6.2B / $1.55B). If it rises above 5.0x, the risk profile changes fundamentally.
Big-3 Panel — where each AI stands
Advanced Analysis Forensic deep-dive · separate lenses
MSCI is a textbook wide-moat compounder: revenue grew from 2.18B to 3.33B (roughly 11% CAGR over four years), gross margin sits at 83% and operating margin expanded from 52.8% to 55.7%, and net income rose from 803M to 1.36B. Free cash flow climbed from 937M to 1.60B with OCF/NI at 1.21x and accruals at -4.4% of assets, indicating reported earnings are more than backed by cash. Altman Z of 5.96 confirms no distress signal despite the levered capital structure. Capital allocation is shareholder-friendly and disciplined: diluted share count fell from 82.4M to 74.3M (-2.6% CAGR), buybacks ran 1353% of SBC, and SBC is a modest 3.6% of revenue. The main structural caveat is a net debt position of ~6.0B against only 356M of cash, so the balance sheet is a constraint rather than a cushion - but 1.6B annual FCF services and amortizes that easily. CEO Henry Fernandez making seven open-market purchases totaling ~2.25M in May 2026 is a strong tone-at-the-top signal, dwarfing the lone 272K insider sale.
Verify before trusting this (5)
- Debt maturity ladder and covenants on the 6B gross debt - refinance risk if any tower is near-dated
- Customer concentration in Index and Analytics segments (top-10 client share of revenue)
- Retention/renewal rates on subscription products (Run-rate retention disclosed in filings)
- Any pending litigation or ESG-product regulatory exposure that could impair the franchise
- Terms and dilution mechanics of any convertible or preferred instruments in the capital stack
The composite fair value of $313.66 and signal-adjusted $314.87 imply roughly -43% downside from $549.78. The DCF at $337.52 is the most credible anchor for a business with 83% gross margins, mid-teens revenue growth, and 1.6B FCF; the EPV floor of $85.40 is clearly a no-growth strawman and should be discounted, while the anchored P/E of $494.20 essentially capitalizes today's multiple and still sits below spot. Even weighting toward the more generous DCF and anchored-PE (blend ~$415), the stock trades ~32% above deserved value. The market is paying for continued double-digit index/analytics compounding, ESG re-acceleration, and durable pricing power - a lot of which is real, but all of which is priced.
Verify before trusting this (5)
- Recurring subscription run-rate and retention by segment (Index, Analytics, ESG)
- Asset-based fee sensitivity to AUM and mix shift
- Guidance on organic revenue growth vs. price vs. new-product contribution
- Interest expense trajectory and refinancing schedule on the $6B debt stack
- Any deceleration in ESG bookings that would break the platform-monopoly narrative
MSCI screens as a durable platform-monopoly, but the tape is not cooperating: VIX at 17.7 (top quartile), S&P off its high, 10y at 5%, and a beta of 1.22 mean this name gets marked down in risk-off pulses more than a typical financial-data defensive would. The narrative is strong and durable but the intensity cuts both ways - with a 75% premium to DCF baked in, sentiment leans on continued belief in structural TAM expansion (ESG, factors, private assets), and any crack in that story is punished asymmetrically. Recent price action confirms the vulnerability: two ~3%+ single-day drops in the last month, one tied to index-reconstitution optics around the MSTR removal proposal - a reminder that MSCI's index-arbiter role generates its own headline risk. Momentum is still positive on a multi-year basis but the 3-year trend has decelerated 3.1pp, and analyst tone is not providing an offsetting tailwind in the brief. Net: not a collapse, but a persistent crosswind on a stock whose premium multiple leaves it exposed to exactly this kind of tape.
Verify before trusting this (5)
- Whether the nascent risk-off regime extends beyond a few days or reverses - MSCI's beta means a durable stress tape matters
- Analyst target revisions post any organic-growth guide - divergence from the 8-10% story would crack the premium
- Further index-reconstitution controversies (MSTR-style) that keep MSCI in adverse headlines
- Fund-flow data on passive/ESG - the core narrative pillar; any maturation signal feeds the bear thesis
- Movement in the 10y - a decisive break lower would meaningfully relieve multiple pressure
The world keeps shifting investable assets toward rules-based, benchmark-referenced vehicles, and that shift mechanically enlarges the toll booth MSCI operates: benchmarks are coordination standards, and standards consolidate rather than fragment. Counterweight is that the buy-side paying the tolls is itself under fee compression, so MSCI's growth increasingly depends on selling more modules into flat client budgets rather than on client prosperity. Macro is the near-term swing factor — higher-for-longer rates and a flat curve pressure asset values and therefore the AUM-linked slice. Nothing in the researched forces suggests disintermediation of the index franchise itself; the credible long-run threats are pricing (self-indexing, ESG data commoditization) rather than volume.
When we made this prediction on Sep 18, 2026, MSCI was $551.73. We expect it to be $520.00 by Mar 2027, and we consider it great value under $415.00. This is an early model (v0.6.0) — the direction is more reliable than the exact price. Made Sep 18, 2026.
Blue is our prediction, starting the day we made it. Grey is a slower route to the same place — the same destination, taking longer. Black is the actual price, so you can see how we are doing.
Post-Report Due Diligence NOTES
Evidence for a closer look, not a verdict — no score or designation on this page has been changed by it. Items marked material are ones where a conclusion above moves to the other side of the price.
trailing_eps
flips up 25%
adjusted_pe
flips up 25%